Drawing for HPLE-LM CARBOHYDRATES

USPTO serial 87571847

HPLE-LM CARBOHYDRATES

Reviewed by CopyMark Law Group

Reg. 6195517Status 700Renewal
Filing date
Status date
Registration date
Nov 10, 2020
Examiner
GULIANO, ROBERT N
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HPLE-LM CARBOHYDRATES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paul C. Llewellyn

Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP601 Massachusetts Ave., N.W.IP DOCKETINGWashington, DC 20001

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industryACTIVEMay 1, 2020
042Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicinesACTIVEMay 1, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 26, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Nov 10, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 10, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 3, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 2, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 14, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 14, 2020EX4GSOU EXTENSION 4 GRANTED—
Sep 14, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 28, 2020EXT4SOU EXTENSION 4 FILED—
Aug 28, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 24, 2020IUAFUSE AMENDMENT FILED—
Aug 24, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 27, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 25, 2020EX3GSOU EXTENSION 3 GRANTED—
Feb 25, 2020EXT3SOU EXTENSION 3 FILED—
Feb 25, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 27, 2019EX2GSOU EXTENSION 2 GRANTED—
Aug 27, 2019EXT2SOU EXTENSION 2 FILED—
Aug 27, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 27, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 25, 2019EX1GSOU EXTENSION 1 GRANTED—
Feb 25, 2019EXT1SOU EXTENSION 1 FILED—
Feb 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 3, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 3, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 13, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 29, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 16, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 16, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 22, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 22, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 22, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 18, 2017DOCKASSIGNED TO EXAMINER—
Aug 24, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 21, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance